Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
19 participants
INTERVENTIONAL
2014-07-31
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis
NCT01766440
A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis
NCT00419666
Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis
NCT02125279
Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis
NCT01582932
Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis
NCT01563068
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
calcitriol ointment
calcitriol 3 mcg/g ointment
calcitriol ointment
placebo
placebo comparator
placebo comparator
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
calcitriol ointment
placebo comparator
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of stable mild to moderate plaque psoriasis
Exclusion Criteria
* Hypercalcemia
* Past history of kidney stones
* Vitamin D deficiency
* Other concomitant dermatological disease
2 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Galderma R&D
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Graeber, MD
Role: STUDY_DIRECTOR
Galderma R&D, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
David Stoll, MD
Beverly Hills, California, United States
Center for Dermatology and Laser Surgery
Sacramento, California, United States
Dermatology Specialists Research
Louisville, Kentucky, United States
University of Mississippi Medical Center
Jackson, Mississippi, United States
RCMC Center for Dermatology at Linden Oaks
Rochester, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Clinical Partners, LLC
Johnston, Rhode Island, United States
Dermatology and Laser Center of Charleston
Charleston, South Carolina, United States
DermResearch
Austin, Texas, United States
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Clinical Trials of Texas
San Antonio, Texas, United States
Jordan Valley Dermatology
West Jordan, Utah, United States
UCL Saint Luc
Brussels, , Belgium
UZ Ghent
Ghent, , Belgium
CHU de Liège
Liège, , Belgium
Winnipeg Clinic, Dermatology Research
Winnipeg, Manitoba, Canada
Universitätsklinikum Erlangen, Hautklinik
Erlangen, , Germany
Praxis Dr.Beate Schwarz
Langenau, , Germany
Universitäts-Hautklinik Mainz, Johannes Gutenberg-Universität Mainz
Mainz, , Germany
Technical University Munich
München, , Germany
University of Tübingen
Tübingen, , Germany
Heim Pál Gyermekkórház; Bőrgyógyászati Osztály
Budapest, , Hungary
Pécsi Tudományegyetem; Bőr-, Nemikórtani és Onkodermatológiai Klinika
Pécs, , Hungary
Szegedi Tudományegyetem, Szent-Györgyi Albert Klinikai Központ; Bőrgyógyászati és Allergológiai Klinika
Szeged, , Hungary
PO G. Rodolico, AOU Policlinico Vittorio Emanuele
Catania, , Italy
Padova University Hospital
Padua, , Italy
University of Parma
Parma, , Italy
Policlinico Tor Vergata
Rome, , Italy
Hospital Universitari Germans Trias i Pujol
Badalona-Barcelona, , Spain
Hospital Sant Joan de Deu
Esplugues de Llobregat, , Spain
Hospital General Universitario Gregorio Marañón
Madrid, , Spain
Hospital Universitario Infanta Leonor
Madrid, , Spain
Hospital Universitario La Paz
Madrid, , Spain
Hospital Universitario Infanta Sofía
San Sebastián de los Reyes, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RD.06.SPR.18132
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.